HR 8529
Protecting Access to Affordable Medicines Act of 2020
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the Protecting Access to Affordable Medicines Act of 2020, aims to lower drug costs for Medicaid recipients. It prohibits pharmaceutical companies from receiving additional rebates for generic drugs (non-innovator multiple-source drugs) when the average manufacturer price is below $1. The goal is to prevent rebates from driving up the overall cost of these medications under the Medicaid program. This legislation focuses specifically on rebates related to outpatient drugs.
Sponsors
Official sponsors from legislative records.
Primary sponsor
G. K. Butterfield
Cosponsors
Billy Long
Dan Bishop
David B. McKinley
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.